Consolidative Radiotherapy Plus Maintenance Chemotherapy for Metastatic Colorectal Cancer
- Status
- UNKNOWN
- Phase
- PHASE2
Clinical Trials Related to Metastatic Colorectal Cancer
Related studies linked through entity extraction aliases.
Study of Apatinib and Capecitabine Combination to Maintain Treating Metastatic Colorectal Cancer
- Status
- UNKNOWN
- Phase
- PHASE2
The Efficacy of Silymarin as Adjuvant Therapy on Colorectal Cancer Patients Undergoing FOLFIRI Treatment
- Status
- COMPLETED
- Phase
- PHASE4
A Clinical Trial of Durvalumab and Tremelimumab, Administered With Radiation Therapy or Ablation in Patients With Colorectal Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Chemotherapy Intensification in Patients With High Lactate Dehydrogenase Values and Soluble Syndecan1 Levels
- Status
- TERMINATED
- Phase
- PHASE2
Phase Ib Study of PDR001 in Combination With Regorafenib in Adult Patients With Previously Treated Metastatic Colorectal Cancer
- Status
- COMPLETED
- Phase
- PHASE1
Validation of a New Prognostic Score for Adult Patients With RAS Wild-type mCRC Treated With Vectibix® and FOLFIRI or FOLFOX in First Line (VALIDATE)
- Status
- COMPLETED
- Phase
- N/A
A Study of OMP-305B83 in Subjects With Metastatic Colorectal Cancer
- Status
- TERMINATED
- Phase
- PHASE1
A Study of Brontictuzumab With Chemotherapy for Subjects With Previously Treated Metastatic Colorectal Cancer
- Status
- COMPLETED
- Phase
- PHASE1
Safety and Pharmacokinetics of Recombinant Anti-EGFr Antibody in Patients With Metastatic Colorectal Cancer
- Status
- COMPLETED
- Phase
- PHASE1
Prospective Translational Study Investigating Molecular Predictors of Resistance and Response to Regorafenib Monotherapy
- Status
- COMPLETED
- Phase
- N/A
High-activity Natural Killer Immunotherapy for Small Metastases of Colorectal Cancer
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
PROSPECT-C: A Study of Biomarkers of Response or Resistance to Anti-EGFR Therapies in Metastatic Colorectal Cancer
- Status
- COMPLETED
- Phase
- N/A
Study of GVAX (With CY) and Pembrolizumab in MMR-p Advanced Colorectal Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Comparison FOLFIRINOX Panitumumab vs mFOLFOX6 Panitumumab in RAS/B-RAF Wild-type Metastatic Colorectal Cancer Patients
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Phase I of SGM-101 in Patients With Cancer of the Colon, Rectum or Pancreas
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Phase II Trial to Assess FOLFIRI+Aflibercept Efficacy in Patients With Oxaliplatin-pretreated Metastatic Colorectal Cancer With or Without ACE Polymorphisms
- Status
- COMPLETED
- Phase
- PHASE2
Sym004 in Metastatic Colorectal Cancer and ECD-EGFR Patients
- Status
- WITHDRAWN
- Phase
- PHASE2
Clinical Evaluation of PET-CT for Staging of Colorectal Lung Metastases
- Status
- COMPLETED
- Phase
- N/A
Metastatic Colorectal Cancer (RAS-wildtype) After Response to First-line Treatment With FOLFIR Plus Cetuximab
- Status
- COMPLETED
- Phase
- PHASE3